Vascular Specialist–July 2021

8 INTERVIEW Southern Vascular Former president reflects on a lifetime of progress and what the future holds for the specialty

Vol.17 No.07 JULY 2021 Official Publication

Featured in this issue:

www.vascularspecialistonline.com

5

10

13

TRANSFORMATION SHAW TAKES HELM OF WFVS

ATHERECTOMY MORE NEW DATA EMERGES

VISTA PROGRAM OKLAHOMA AND VASCULAR DESERTS

PAD

Mills becomes next SVS vice president

FIGHTING THE GOOD FIGHT

BY BETH BALES Society for Vascular Surgery (SVS) members elected Joseph Mills, MD, of Baylor College of Medicine in Houston, Texas, as their next vice president, a result announced during the Virtual Annual Business Meeting last month.

He now joins a line of succession that includes the new and incoming SVS President Ali AbuRahma, MD, and Presidentelect Michael C. Dalsing, MD,

The case for multidisciplinary limb salvage in face of increasing diabetes, diversifying nation

BY BRYAN KAY

who will follow AbuRahma in the presidential chair next year. The digitally hosted business meeting took place June 16.

Mills is chief of the division of vascular surgery and endovascular therapy at Baylor. He was previously professor and chief of vascular surgery at the University of Arizona College of Medicine and co-director of the Southern Arizona Limb Salvage Alliance (SALSA).

DRAMATIC INCREASES IN RATES OF DIABETES— particularly among Black females—through 2060 underscore the importance of a multidisciplinary team approach to limb salvage, according to Vincent Rowe, MD, professor of vascular surgery and endovascular therapy in the Keck School of Medicine at the University of Southern California (USC), Los Angeles.

Rowe was speaking before the Pacific Northwest Endovascular Conference (PNEC) in Seattle during which he made the case for the multispecialty method—why it works and how other centers might go about embracing it rather than fighting it. To that end, he informed the PNEC gathering (May 27–28), when he first started to talk on the topic a few years ago, his institution did not See page 6

Vascular Specialist 9400 W. Higgins Road, Suite 315 Rosemont, IL 60018

CHANGE SERVICE REQUESTED

Presorted Standard U.S. Postage PAID Permit No. 384 Lebanon Jct. KY

GUEST EDITORIAL

The choice between autonomy, true partnership—or the slow drift to ‘thralldom‘

Bhagwan Satiani

BY BHAGWAN SATIANI, MD

ANTHONY VALDÉS, MBA, THE PRESIDENT OF Tampa, Florida-based Collaborative Health Systems, declares that what physicians want is to “deliver great clinical outcomes, get paid fairly for that care, and stay independent.” It is becoming clearer with every passing year that, while we do, for the most part, deliver great clinical outcomes, and many physicians do not think we get paid fairly for providing that care, the hopes of remaining independent appear to be fading for many of us surgeons. And by physician independence, I am assuming that implies autonomy to make decisions in all things related to the practice of medicine.

Over time, some of us may feel we are facing up to a state of what might be called thralldom—or held in a kind of bondage-type relationship—and we are, thus, looking for other options. In general, other than to retire early, the conventional choices left to us are perhaps to remain independent within a specialty or multispecialty group; accept employment in an academic, private or government health system; choose another career; or seek out novel ways to remain in practice.

Novel options may include to stay in practice but consider non-traditional or even provocative paths. While office-based labs (OBLs) and ambulatory surgery centers (ASCs) are now mainstream, new actors are in play.

Putting the traditional deep-pocket potentates to one side, some colleagues have taken up employment with device makers, pharmaceutical companies, and even Wall Street outfits. The job may start part-time, but, if both parties are satisfied, the physician acquires some relevant new knowledge or a business degree, and then segues to

VASCULAR SPECIALIST Medical Editor Malachi Sheahan III, MD Associate Medical Editors Bernadette Aulivola, MD, O. William Brown, MD, Elliot L. Chaikof, MD, PhD, Carlo Dall’Olmo, MD, Alan M. Dietzek, MD, RPVI, FACS, Professor Hans-Henning Eckstein, MD, John F. Eidt, MD, Robert Fitridge, MD, Dennis R. Gable, MD, Linda Harris, MD, Krishna Jain, MD, Larry Kraiss, MD, Joann Lohr, MD, James McKinsey, MD, Joseph Mills, MD, Erica L. Mitchell, MD, MEd, FACS, Leila Mureebe, MD, Frank Pomposelli, MD, David Rigberg, MD, Clifford Sales, MD, Bhagwan Satiani, MD, Larry Scher, MD, Marc Schermerhorn, MD, Murray L. Shames, MD, Niten Singh, MD, Frank J. Veith, MD, Robert Eugene Zierler, MD Resident/Fellow Editor Laura Marie Drudi, MD Executive Director SVS Kenneth M. Slaw, PhD Director of Membership, Marketing and Communications Tara J. Spiess CAE Managing Editor SVS Beth Bales Marketing & Membership Specialist Anna Vecchio

4 | Vascular Specialist

an executive role that comes fully equipped with stock options. And now there are even newer, more powerful capitalist players with deeper pockets still. Amazon, with a current market cap exceeding $1.7 trillion, is launching Amazon Care for its employees in all 50 U.S. states, hiring 3,000 new corporate types and offering virtual care just as a start. Not so long ago, the mega insurer UnitedHealth Group, which already has 30,000 employed or affiliated physicians (Optum), completed a $4.9-billion acquisition of DaVita Medical Group, which employs 13,000 physicians.

It is now well on the way to becoming the largest single employer of physicians.

Probably the biggest earthquake was the entrance of private equity players. These outfits can be lucrative sources of funding whose methods involve investing institutional capital in order to purchase operating entities, as in physician practices. Our recent review of the pros, cons and risks of being part of a private equity structure is concerning.1 COVID-19 has had a deleterious effect on the number of deals in North America, with buyout volume and value both dropping in 2020, the latter by 25% to $34.7 billion from 2019. Although it is still early, employment with private equity-owned practices is the newest but untested kid on the block. Provider (oh how I abhor that term!) deals were the most frequent, falling to 52% of all deals—the relevant figure was 60% in 2019.

Growth has occurred in other sectors of healthcare: information technology, telehealth support, payors, medical technology companies, biopharma and life sciences in general, and next-generation models of care like home care. What does strike as particularly surprising

Putting the traditional deeppocket potentates to one side, some colleagues have taken up employment with device makers, pharmaceutical companies, and even Wall Street outfits is that, in the provider area, surgical-type practices are represented in the majority (>50%). Granted, most could be classed as either ophthalmology, ear nose and throat (ENT), or dermatology, but specialty surgery practices may not be far behind. So why are private equity outfits attractive to physicians? For doctors who are either looking for an exit or not risk averse, there is an opportunity to be a participant in the private equity companies’ playbook. This means bringing in new management, creating efficiencies, offering and delivering more services, negotiating with payors for higher reimbursement, and micromanaging finances with the aim of selling the practice. This, of course, results in a share of the hefty profit yield a few years down the line. Although the continued on page 6

Vascular Specialist is the official newspaper of the Society for Vascular Surgery and provides the vascular specialist with timely and relevant news and commentary about clinical developments and about the impact of healthcare policy. Content for Vascular Specialist is provided by BIBA Publishing. Content for the News From SVS is provided by the Society for Vascular Surgery.

POSTMASTER: Send changes of address (with old mailing label) to Vascular Specialist, Subscription Services, 9400 W. Higgins Road, Suite 315, Rosemont, IL 60018.

The ideas and opinions expressed in Vascular Specialist do not necessarily reflect those of the Society or the Publisher. The Society for Vascular Surgery and BIBA Publishing will not assume responsibility for damages, loss, or claims of any kind arising from or related to the information contained in this publication, including any claims related to the products, drugs, or services, or the quality or endorsement of advertised products or services, mentioned herein.

For missing issue claims, e-mail subscriptions@bibamedical.com.

The Society for Vascular Surgery headquarters is located at 9400 W. Higgins Road, Suite 315, Rosemont, IL 60018.

RECIPIENT: To change your address, e-mail subscriptions@bibamedical.com.

Vascular Specialist (ISSN 1558-0148) is published monthly for the Society for Vascular Surgery by BIBA Publishing.

Printed by Elk Grove Graphics

©Copyright 2021 by the Society for Vascular Surgery

Published by BIBA Publishing, which is a subsidiary of BIBA Medical Ltd. Publisher Roger Greenhalgh Content Director Urmila Kerslake Managing Editor Bryan Kay bryan@bibamedical.com Editorial contribution Jocelyn Hudson, Suzie Marshall, Will Date and Jamie Bell Design Terry Hawes Advertising Nicole Schmitz nicole@bibamedical.com Letters to the editor vascularspecialist@vascularsociety.org

BIBA Medical, Europe 526 Fulham Road, London SW6 5NR, United Kingdom BIBA Medical, North America 155 North Wacker Drive – Suite 4250, Chicago, IL 60606, USA

July 2021

GLOBAL PRACTICE

WFVS undergoes transformation, looks for vascular ’haves‘ to better help ‘have nots‘

BY BRYAN KAY

The World Federation of Vascular Societies (WFVS) has entered a new era of transformation, seeking to better pave the way for disparate vascular surgeons and societies to disseminate the latest science and best practices to every corner of the globe.

I

n what is planned to be a two-year transitional period, the WFVS will now be housed administratively under the aegis of the Society for Vascular Surgery (SVS) and led by new SecretaryGeneral Palma Shaw, MD, the current chair of the SVS International Relations Committee.

The WFVS, currently led by Australiabased President Peter Subramaniam, MBBS, is an amalgam of membership societies from every continent, including the SVS in North America, the European Society of Vascular Surgery (ESVS) and the Asian Society for Vascular Surgery. Its core mantra involves connecting member societies in order to foster international scientific discourse, share knowledge of effective therapies and interventions, and impart developments in vascular specialist training strategies.

Previously, the federation would host an annual meeting in the home country of the reigning president, who would also assume its administrative home, with member society participants travelling from across the world to attend.

In the new era, Shaw and SVS staff will seek to establish a sustainable future for the WFVS through a fixed administrative abode as well as ongoing live meeting events housed on a digital platform. The plans are the result of a memorandum of understanding recently agreed between the WFVS, the SVS and the ESVS. “The WFVS mantra will remain the same but this is, in fact, an evolution,” explains Shaw, a professor of surgery at the State University of New York, a member of the division of vascular surgery at Upstate Medical Center in Syracuse, New York, and also the program director of the vascular fellowship at the same institution, in an interview with Vascular Specialist.

Shaw was tapped for the role of secretary-general by outgoing SVS President Ronald L. Dalman, MD, and Executive Director Kenneth M. Slaw, PhD, owing to her experience on the International Relations Committee. She is believed to be the first female leader within the organization, and will be joined by Wei Zhou, MD, a professor

July 2021

of surgery and the chief of the division of vascular surgery at the University of Arizona College of Medicine-Tucson, Arizona, who will be the second SVS representative to the WFVS council of officers.

The post-pandemic era of virtual meetings helped inform the need for a digital-based future for WFVS meetings, said Shaw. “We’re proposing that there is a migration from an annual WFVS live event to an ongoing digital platform,” she continues. “The support provided will be such that we will help transition the WFVS to a sustainable, virtual, digital platform, and it won’t be anticipated that members are obligated to attend live events or meetings, although we can hold live meetings if we choose to.

“Additionally, there has been this rotating administrative home housed wherever the president is, and it would change every year. It really wasn’t providing a lot of stability for this society.

So, the governance and administrative home needed to be set and established.

Also, they didn’t have resources, because they don’t really charge dues, with the $1,000-a-year fee for each society not really amounting to much except to support the website. We also thought the mission could be broadened.”

Governance of the WFVS will be retained by the Federation Council through its soon-to-berevised bylaws and constitution.

The transformation will include a new website and the recruitment of a part- or fulltime international relations manager. Shaw will remain in post for the duration of the two-year transition, working alongside Slaw with the ultimate goal of long-term sustainability and completing the Federation’s digital re-birth.

“It’s an aggressive lift but I think it’s very exciting and very doable,” comments

The global reach of the WFVS membership

Shaw, who feels particularly prepared for the secretary-general role having taken up the reins mere days after graduating with an executive MBA. “I’ve had many conversations with the existing leadership, the president, the outgoing secretarygeneral, all of the council members.”

A presidential changing-of-the-guard is due in October, and a secretary-generalelect is also in place in the form of Juan Paolini, MD, the current treasurer of the Latin American Association of Vascular Surgery. The new set-up will be reassessed in two years, with a pulse-check coming at the 2022 Vascular Annual Meeting

“We’re proposing that there is a migration from an annual WFVS live event to an ongoing digital platform” — Palma Shaw

Palma Shaw

(VAM), where a WFVS session is planned.

“The reality is, I don’t think that, even in this era, even when COVID goes away, we can go back to live meetings for the WFVS every year,” reflects Shaw.

“Think about the limitations of requiring people to travel all over the world—from Australia to go to Boston, or from India to go to Australia or South America. The last in-person WFVS meeting, which I went to in 2018, was wonderful, but people had to travel from places like Australia to South America. The distances can be great.

“What we can actually do—and I really think this is the way things are going—is we use a virtual platform to hold things together, to educate and communicate to keep moving things forward, and then we have periodic in-person meetings.”

The fundaments of spreading up-todate developments in vascular science to those pockets of the globe that might not otherwise have access to the latest best practice remain at the core of WFVS, adds Shaw. “Out of this terrible pandemic, we’re going to capitalize on a lot of good things that we’ve learned to optimize our strategy, to work together in a societal way, to disseminate information to those people that have not,” she says. “There are people, for example in Africa, in the Philippines, and in other parts of the world, who don’t have the means to have the latest information. Some don’t have a society to represent them. There are people practicing vascular surgery who can’t leave where they are because they might be the only vascular specialist in the whole region. They can’t go to a vascular meeting or attend the SVS meeting to learn the latest.

“This is a collaborative effort to organize the vascular societies with resources, to reach those still developing: All of the societies, which are designed mostly by continent, and their leaders collaborate and exchange ideas so that everybody benefits—so no one continent is held back.

We bring everybody together on the virtual platform, increasing our communication dramatically by doing so.”

vascularspecialistonline.com | 5

GUEST EDITORIAL continued from page 4

number of practices owned by private equity players is unknown, the Medicare Payment Advisory Commission (MedPAC) estimates these entities bought at least 2% between 2013 and 2016, after which acquisitions picked up.

Paul Ginsburg, MedPAC vice-chairman, recently noted: “Private equity is more aggressive. The loopholes in our payment systems will be exploited more rapidly.” Federal and state prosecutors are now investigating private equity companies over excessive loans from the Small Business Administration’s COVID-19 Paycheck Protection Program.

Another new term we may become familiar with is the special purpose acquisition company (SPAC). This is another option for private equity-owned medical groups looking to exit arrangements after three-to-seven years as an alternative to an initial public offering (IPO). SPACs avoid the labor-intensive IPO process by allowing a shell

PAD

corporation to take the company public. The existential question for doctors is this: How do we take control of our own destiny? Or has the horse bolted from the barn already? Are we now on the road to what Friedrich Hayek called the road to serfdom? A lot depends on how the current generation of physicians sees the security of employment in exchange for the freedom of owning their own practices. While we deal with conflicts of interest regularly, the pressure to produce is a step up from work relative value unit (wRVU)-based compensation models

The existential question for doctors is this: How do we take control of our own destiny? Or has the horse bolted from the barn already?

and may be a leap too far. Are we ready for the intense probes that will surely follow? Will we be just about anyone’s chauffer? At this juncture, I would recommend reading Carl Hauser’s thought-provoking presidential address at the Western Trauma Association.2 References 1. S atiani B., Zigrang T.A., Bailey-Wheaton J.L. Should surgeons consider partnering with private equity investors?

The American Journal of Surgery. 2020 Dec 19; S00029610(20)30806-0. doi: 10.1016/j.amjsurg.2020.12.028.

2. Hauser C. Ownership. J Trauma Acute Care Surg. 2017. Volume 83, Number 5

BHAGWAN SATIANI is professor emeritus in the division of vascular diseases and surgery in the College of Medicine at The Ohio State University, Columbus, Ohio. He is an associate medical editor of Vascular Specialist.

COVER STORY

Fighting the good fight The case for multidisciplinary limb salvage in face of increasing diabetes, diversifying nation continued from page 1

have such a limb salvage program, leading him to declare that his talk should actually be entitled, “How we realized we needed to build one.”

An overall growth in the number of people developing diabetes looms large, explained Rowe. “We found out that we needed the program when we started seeing a lot cases such as this case here,” he said, pointing to a slide depicting major tissue damage to the foot. “These are cases of combined problems with circulation and the foot in terms of tissue loss and deep infection. The reason why we were seeing more of these things was because of the exponential growth of diabetes.”

Rowe referenced some key statistics: More than 34 million people of all ages—about one in 10—have diabetes, and 88 million adults, or one in three, have prediabetes. Diabetes complications are increasing for young adults aged 18 to 44 and middle-aged adults aged 45 to 64. Diabetes is more common among Asians, non-Hispanic Blacks, and Hispanics than non-Hispanic whites. Nearly one in five adolescents aged 12 to 18 and one in four young adults aged 19 to 34 have prediabetes “The patients we have talked about, mainly for peripheral vascular disease, who have worse outcomes are Black and Hispanic,” Rowe continued. “We’re seeing that diabetes is more common in that group. This is not only going to increase the complexity of these patients with 6 | Vascular Specialist

diabetes, but it’s going to make the overall At the outset of the outcomes that they have worse, because program at USC, the there will be more of them. It’s sort of a various specialties were doubling project, where there’s going to be siloed. “When we looked more patients with the problem and then at things, we just saw more disease presence.” them differently, and Referencing sourced data, Rowe took a couldn’t agree,” he said. look at the pediatric population, explaining: Then the BEST-CLI “We’re dealing with a more diverse nation.

(Best endovascular vs.

The total population of people considered best surgical therapy in minorities is about 38%. But for children patients with critical limb under five, it’s about 50%. That’s from ischemia) trial came along, 2014, so I’m sure that has increased. We are highlighting the need for going to have a more diverse nation and two different specialties we have to be prepared for that, especially to be involved with CLI if the diversity is involving patient groups patients in some of the that are at risk for diabetes. We have major medical centers. tracked the increase in diabetes up to 2060, “We wanted to be Vincent Rowe and the prevalence was shown as going to a part of the trial, increase, especially a prediction so in 2014 it forced myself among Black females that and a cardiologist to there was going to join forces,” Rowe be a huge increase, explained. “Since and an increase in we did that, under those identified the aegis of the as Black males. trial, we began These groups working much are going to be closer together, the ones we’re and doing dealing with in better for our terms of trying patients as a to treat their team.” lower-extremity In the problems.” meantime, Rowe The argument observed, since in favor of a limb the turn of the salvage program extends century the number of to five-year mortality rates publications dealing with among patients who the multidisciplinary undergo a major to “We are going to have a approach amputation, noted limb salvage has more diverse nation and skyrocketed. Most Rowe. These patients are more likely to we have to be prepared of those studies die in five years than a lowering of for that, especially if the show people with a host amputation rates after diversity is involving of cancers, excluding the establishment lung cancer. “Once patient groups that are of a limb salvage you deal with a program, Rowe at risk for diabetes”— patient who gets an added. The USC amputation, their Limb Salvage Vincent Rowe life expectancy goes Center contains down dramatically.” vascular surgeons,

interventional cardiology, vascular medicine, a nurse practitioner, a research coordinator, fellows from vascular surgery and vascular medicine, podiatry, plastic surgery, wound care specialists, endocrinology practitioners and nutritionists, among others. Crucial roles are played by podiatry and plastic surgery, Rowe said, along with wound care, nutrition and physical therapy. “And I don’t think we use this team enough: the endocrine specialists.”

David Armstrong, DPM, co-director of the USC Limb Salvage Center, dubbed the service the “Hot Foot Line.” Patients call the line, with subsequent wounds assigned to podiatry if they bear good circulation and are mainly due to infection, and sent to vascular surgery should there be an issue with circulation. Rowe and colleagues compared patient outcomes from before the start of the program when practitioners siloed, to afterwards when they were combined into a limb preservation clinic.

“We saw benefits in the amputations rates in high amputations rates, or high up the leg, and we saw a decrease in low amputations as well. We also saw an improvement in the metric from the highto-the-low ratio.”

The USC team’s data is not yet published but Rowe and colleagues conclude that the multidisciplinary approach to limb salvage bears a number of benefits, including in amputation rates and length of stay. Rowe also touched on limitations. “One of the main ones is staffing and clinic space, as well as operating time, because we end up doing a lot of shared procedures,” he said.

“I’ll do something to help the circulation, and then the podiatrist will come in and clean up a part of the foot, or do a partial foot amputation, all in the same setting, so it prolongs the operating time.”

July 2021

SOUTHERN VASCULAR

A lifetime of achievement: Former SVS president looks back on career milestones

BY BRYAN KAY

The first time Bruce A. Perler, MD, attended the Southern Association for Vascular Surgery (SAVS) annual meeting, he was a young faculty member who had already started developing the keen interest in carotid disease for which he is now well known, but otherwise a selfdescribed “nobody” in the company of greatness.

I

t was 1986, and he was attending an evening reception, when, from across the other side of the room, he spotted Jesse E. Thompson, MD, “the dean of carotid disease,” who, to Perler’s surprise, suddenly walked across to introduce himself to the up-and-comer. “Then he led me back across the room to meet his wife,” remembers Perler. “Here’s this major hero of mine, this iconic figure in vascular surgery, talking to a nobody.” It was a seminal moment for Perler, an interaction epitomizing to him the culture of SAVS, “what makes it such a special organization—not just great science, but the collegiality, friendship and mutual respect.”

The encounter might be viewed as a portentous moment in the career of the Johns Hopkins Hospital, Baltimore, Maryland, Julius H. Jacobson II, MD, endowed chair in vascular surgery, vice-chair for clinical operations, and chief emeritus of the division of vascular surgery and endovascular therapy. Thompson was the first-ever recipient of the prestigious Rudolph Matas Lifetime Achievement Award, which SAVS bestows to recognize a lifetime of excellence, achievement and contributions to the field of vascular surgery. Now, Perler joins a small band of Matas awardees as the latest following in the wake of the man for whom the accolade is named and who was once hailed “the father of vascular surgery.”

Perler’s route to the gilded award is not inconsiderable.

The list of career milestones and accomplishments belonging to him require breathless delivery to achieve relative brevity. But incoming Society for Vascular Surgery (SVS) President Ali AbuRahma, MD, one of a trio of former SAVS presidents behind his nomination, makes a fist of it in his formal letter of recommendation.

A sampling: Vascular chief. SVS president. A consultant to the Circulatory System Devices Panel of the Food and Drug Administration (FDA). Executive vice president of the American Board of Surgery-Vascular Surgery Board (ABS-VSB). Chair of the SVS Foundation. President of the Eastern Vascular Society. And, the most relevant past role in the context of AbuRahma’s compiling of the list: SAVS president.

“It seems that we tend not to see much of the past presidents, but not Dr. Perler,” AbuRahma commented in his letter. “In spite of Dr. Perler’s busy schedule, he has not 8 | Vascular Specialist

missed one single [SAVS] meeting over the past 25 years.

In summary, I believe Dr. Perler is most deserving of the Matas award given all that he has done, not only for the SAVS, but the field of vascular surgery.”

Rarely bestowed honor

an incredibly important financial asset of the Society for Vascular Surgery, and I’m very proud of the nearly eight years that my co-editor, Tony Sidawy, MD, and I had, and the condition in which we left the journal, and also that we started two new journals, the Journal of Vascular Surgery: Venous and Lymphatic Disorders, and the SVS’ first open access journal, the Journal of Vascular Surgery: Cases and Innovative Techniques.”

Looking ahead, Perler sees a bright future for the vascular specialty. “These are tough times for medicine in general and tough times for vascular surgery, but I think it was Albert Einstein who said, ‘In difficulty lies opportunity,’” he says. “I think vascular surgery has enormous opportunity moving forward. The patients we serve are only going to increase in number, we’re one of the—if not the—most innovative specialties in medicine and surgery. New treatments, whether they be technological or medical, stem cell or the use of artificial intelligence, I think the future is bright. It’s really incumbent upon us senior surgeons to encourage as many bright young people to become interested in the field, get them into the field, and make those contributions.”

Gilbert R. Upchurch Jr., MD, the immediate past SAVS president, who formally handed Perler the award, pointed out the accolade is not given yearly but to individuals who have shown continued and persistent leadership to the Society over the years—last being awarded in 2017.

“Dr. Perler has accomplished everything there is to accomplish in vascular surgery,” he said. “He is a brilliant scholar with a quick wit. He is functionally undefeated in any debate regarding vascular surgery as his debate skills are unparalleled. He has edited the JVS and presently serves as the editor of Rutherford’s Vascular Surgery and Endovascular Therapy. He remains a tireless supporter of the SAVS.” Yet Perler himself, presented with this list, first returns to his presence in the company of Thompson 35 years ago, commenting, “I’m obviously proud of my contributions to the specialty and the leadership positions I’ve been entrusted with over the years, but, ultimately, ‘Be yourself’ I still consider myself primarily and, most importantly, For those potential future vascular surgeons, Perler has to be what I was in 1986, a vascular surgeon,” he tells a message: Seize on opportunities when they present Vascular Specialist. His career interests themselves. He also offers pearls of cover the entirety of the vasculature “I’ve always believed wisdom for the vascular career beyond. and beyond to vascular surgery’s place always believed the toughest thing the toughest thing “I’ve in the firmament of medicine. “I take in the world is to try to be somebody in the world is to care of the totality of vascular disease you’re not,” Perler says. “The easiest thing but I’ve always had a special interest in try to be somebody to do is to be yourself, and that’s how carotid disease and stroke prevention,” conducted my professional life. I’m you’re not. The easiest I’ve he continues. “I feel truly blessed to be honest, I think I do the right things for thing to do is to be the right reasons, and try to treat people a vascular surgeon, and to be entrusted to care for the vascular surgical needs yourself, and that’s right. I think people pick up on that, they of my patients. I’m a great fan of that, and that’s how you get to how I’ve conducted recognize James Collins, the business writer, who be asked to be president of this, or editor my professional life” of that. Once given those opportunities wrote something along the lines of, ‘It’s impossible to have a great life unless ­— Bruce A. Perler you have to deliver. I’ve observed that it’s a meaningful life, and it’s difficult people aspire to positions of leadership to have a meaningful life without for one of two reasons: Some people meaningful work.’ I can’t think of more want to be something, and other people meaningful work, or a better way to spend one’s want to do something. I think ultimately the professional life, than caring for the surgical people who want to do something are the needs of our patients.” ones who are going to be successful.

That’s how I’ve tried to conduct my Longitudinal vascular care professional life. As in basketball, let Perler holds up vascular surgery as a the game come to you. But when singular discipline within the treatment opportunities arise, seize those of the vasculature. “We’re truly unique opportunities and give it all you have. among those who care for vascular To receive a lifetime achievement disease,” he says. “I talk often about award, for this old burned-out taxi vascular surgery exceptionalism—not that driver that I used to be, and who we’re better than the others; we’re not; still carries his taxi driver’s license in but we are unique in so many ways. We’re his wallet to remind him of his roots, exclusively devoted to the care of vascular is enormously humbling and kind of disease; we provide the totality of care— overwhelming.” medical therapy, endovascular and open surgery— and we follow our patients for life. I literally have Bruce A. Perler patients I’ve been following for 20 years or longer.”

Perler considers himself fortunate to have been entrusted with numerous leadership positions, but one role in particular stands out. “I think one of the most important jobs I’ve ever had was to be co-editor of the Journal of Vascular Surgery, which not only symbolizes vascular surgery leadership in the care of circulatory disease, but as July 2021

THIS ADVERTORIAL IS SPONSORED BY PHILIPS

The latest innovation in intravascular ultrasound: Reconnaissance PV .018 OTW digital IVUS catheter FRANK R. ARKO III, MD

Intravascular ultrasound (IVUS) is now used in a wide variety of peripheral vascular interventions after having first been utilized in coronary circulation in the late 1980s. The increased complexity of endovascular interventions has required improved imaging, and IVUS is the one tool besides angiography that can easily allow direct visualization of the vessel and improve outcomes. IVUS-guided interventions resulted in a significantly larger mean diameter while reducing the odds of TLR (target lesion revascularization) at 6-, 12-, 18-, 24-, months in coronary studies. Lesions at high risk were studied in a randomized controlled trial of 150 patients. IVUS use resulted in larger minimal lumen gain, a lower six-month restenosis rate, while TLR at 12 months was also significantly decreased.1 THE USE OF IVUS IN PERIPHERAL the Stellarex drug-coated balloon (DCB). interventions, while not randomized, has Completion arteriogram showed marked demonstrated improved outcomes—for improvement in flow but a possible example, in aortoiliac occlusive disease.2 dissection in the mid-segment of the In a retrospective analysis of 1,198 SFA. IVUS’ unique ChromaFlo feature patients (28% critical limb ischemia [CLI]) was then used to identify and confirm to investigate whether IVUS improves the areas of dissection (see figure 2). primary patency following nitinol Most of the vessel had significant luminal stenting for TASC II A–C femoropopliteal gain but there were multiple areas of lesions, 2,324 propensity score-matched short-segment dissection. These were patients were compared with those then treated with placement of a total of treated without IVUS. IVUS six Tack Endovascular System was used in 22% of the overall implants. The Tack implants population—in those with more were then post-dilated using severe TASC classification— plain old balloon angioplasty with a mean follow-up of 1.9 (POBA). Completion angiogram +/– 1.5 years. Five-year patency and IVUS (see figure 3) was 65% compared to 35% for demonstrated resolution of the patients with and without IVUS dissections. Follow-up ABI was Frank R. Arko III 0.95 at rest. (p<0.001), respectively.3 The benefits of utilizing Case review IVUS have been shown in the literature.

Here, we present a case of a severely In nearly every vascular bed studied, we limited claudicant who presented with have seen an improvement in overall three years of worsening calf pain. The outcomes. Over the last several years, patient was a prior smoker who was especially with the introduction of DCBs, treated with maximum medical therapy as well as atherectomy, there has been and a walking program. This initially a move away from utilizing the use of improved the symptoms, but after three stents to minimize in-stent restonosis, months she regressed. Exercise anklestent fractures and stent thrombosis. The brachial indices (ABIs) were performed.

Tack system optimizes percutaneous At rest, the ABI on the left leg was 0.67. transluminal angioplasty (PTA), especially With exercise this decreased to 0.17. with DCB therapy, to individually treat On the angiogram, there was a long dissections and to avoid the need to place segment stenosis of the superficial artery long segments of stents. In reviewing (SFA), but otherwise there were threedata on PTA with Tack and PTA alone, vessel runoffs to the foot (see figure 1). there was a marked improvement in the Pre-intervention IVUS was used to size primary patency of 67–87% in patients the diameter of the SFA through the treated with a DCB compared to 95% long segment of diseased artery. Pre12-month patency in patients treated dilatation was performed followed by with DCB and Tack.4 This case shows the

July 2021

1. Angiogram of the superficial artery demonstrating severe stenosis

It is constructed with a stainless-steel shaft for improved pushability. The over-thewire design also allows for fluid infusion up to 300psi, easy guidewire exchanges between 0.014 and 0.018, and an extra 15cm working length.

The Tack system is a first-of-its-kind dissection repair device that allows for precision treatment of peripheral arterial dissections following balloon angioplasty in both above- and below-knee lesions.

The device comes in various sizes. There are four or six preloaded Tack implants for the below- and above-knee systems, respectively. The system is accurate to <=1mm deployment. The Tack itself is made out of nitinol with gold markers.

It has been studied in the TOBA trials.4–6 These studies demonstrate that post-PTA dissection repair with the Tack system improves outcomes for both POBA and DCB angioplasty for patients with peripheral arterial disease (PAD) and CLI. The case example shows how these systems can be combined to improve outcomes and improve long-term patency.

References

2. ChromaFlo feature via IVUS, visualizing short segment dissection

3. Post-treatment, confirming Tack apposition and flow

“The case example shows how these systems can be combined to improve outcomes and improve long-term patency by seeing within the vessel” utility of utilizing IVUS with a DCB to allow for treatment with the Tack system, minimizing the need for longer stents.

Featured products The newly developed Reconnaissance PV .018 OTW IVUS has several benefits that allow for improved image quality and durability, and enhanced catheter design with an over-the-wire platform. It is easily deliverable through complex lesions due to enhanced tapered tip, improved hydrophilic coating, and is 5F compatible.

1. M edical Advisory Secretariat. Intravascular ultrasound to guide percutaneous coronary interventions: An evidencebased analysis. Ont Health Technol Assess Ser. 2006;6(12):1–97. Epub 2006 Apr 1.

PMID: 23074482; PMCID: PMC3379536.

2. Arko F., Mettauer M., McCollough R., et al. Use of intravascular ultrasound improves long-term clinical outcomes in the endovascular management of atherosclerotic aortoiliac occlusive disease. Journal of Vascular Surgery. Apr 1998; volume 27, issue 4, P614–623.

3. Iida O., Takahara M., Soga Y., et al.

Efficacy of intravascular ultrasound in femoropopliteal stenting for peripheral artery disease with TASC II class A to C lesions. J Endovasc Ther. 2014 Aug;21(4):485–92. doi: 10.1583/144721R.1. PMID: 25101575.

4. Brodmann M., Wissgott C., Brechtel K., et al. Optimized drug-coated balloon angioplasty of the superficial femoral and proximal popliteal arteries using the Tack Endovascular System: TOBA III 12-month results. Journal of Vascular Surgery. Volume 72, Issue 5, 2020, Pages 1636–1647.

5. Gray W., Cardenas J., Brodmann M., et al. Treating post-angioplasty dissection in the femoropopliteal arteries using the Tack Endovascular System: 12-Month results from the TOBA II study. JACC. 2019 Dec, 12(23) 2375–2384.

6. Geraghty P.J., Adams G.L., Schmidt A., et al, on behalf of the TOBA II BTK Investigators. Twelve-month results of Tack-optimized balloon angioplasty using the Tack Endovascular System in belowthe-knee arteries (TOBA II BTK). Journal of Endovascular Therapy 27.4 (2020): 626–636.

FRANK R. ARKO III is chief of vascular and endovascular surgery, and co-director of the Aortic Institute at Sanger Heart & Vascular Institute, Atrium Health, in Charlotte, North Carolina. Arko has been compensated for his services for Philips’ further use and distribution.

vascularspecialistonline.com | 9

LOWER EXTREMITY

Atherectomy: ‘Costly interventions do not necessarily correlate with good results’

BY BRYAN KAY

STENTING REDUCED MORTALITY RISK IN patients undergoing interventions for peripheral arterial disease (PAD) by more than 30% when compared to plain balloon angioplasty, and 40% contrasted with atherectomy, a recent propensity-matched analysis found.

The Vascular Quality Initiative (VQI)-derived data drew sharp conclusions from lead investigator of the study, Dipankar Mukherjee, MD, who trailed his probe into the effects of PAD interventions on survival to most recent follow-up by highlighting that most of these procedures involve claudication patients.

“Expensive interventions do not necessarily correlate with good results,” Mukherjee told attendees of the International Symposium on Endovascular Therapy (ISET) held in Miami (May 9–11), where he presented his findings. “What has been good for the bottom line of the OBL [office-based lab] may be fatal for the patient.

We recommend a critical reappraisal of the treatment paradigm for PAD patients presenting with claudication.

We believe the current CMS [Centers for Medicare & Medicaid Services] reimbursement for atherectomy has resulted in unintended consequences.”

Mukherjee, chief of vascular surgery at Inova Fairfax Hospital in Falls Church, Virginia, earlier set out the current context of PAD interventional practice: While PAD

10 | Vascular Specialist

interventions double every decade, the more severe form angioplasty (95% confidence interval [CI], 0.6–0.82; of the disease, critical limb ischemia (CLI), occurs in only p<0.001), Mukherjee revealed. The research team a small percentage. More than a decade ago, there were uncovered no difference between balloon angioplasty and CMS payment system changes governing the outpatient atherectomy (HR, 1.02; CI 0.88–1.19; p=0.776 ), while setting. That led to the rise of the OBL, where stenting was found to be superior to atherectomy most PAD interventions are now carried out.

(HR, 0.6; CI, 0.48–0.75; p<0.001).

Atherectomy, most frequently performed When claudication patients were in OBLs, is the most highly compensated separated from those with CLI, PAD intervention.

Mukherjee and colleagues discovered For the study, Mukherjee and a survival benefit in favor of stenting colleagues plumbed the VQI database over balloon angioplasty (HR, 0.49; CI for claudication and CLI interventions 0.4–0.59; p<0.001). They detected no performed between May 2011 and difference between angioplasty and February 2020. Procedures were classified atherectomy, but their data demonstrated as either balloon angioplasty alone, a “highly significant” HR of 0.55 in stenting with and without a balloon, and favor of stenting vs. atherectomy (CI, atherectomy with or without stenting or 0.43–0.69; p<0.001). “When we look at a balloon. The researchers compared CLI alone, there was a trend toward three cohorts: those receiving balloon significant,” Mukherjee added.

“We recommend a angioplasty vs. those who underwent Discussing his findings, Mukherjee stenting; patients who received balloon critical reappraisal of the told ISET delegates that investigators treatment paradigm for have reported “almost universal angioplasty vs. patients undergoing atherectomy; and those who had a PAD patients presenting evidence” of distal embolization with stent placed vs. atherectomy. peripheral atherectomy. “We know with claudication” — A total of 15,281 patients were that intermittent claudication has a included: 9,441 received balloon Dipankar Mukherjee relatively benign course with a very angioplasty, 3,547 got a stent and small annual mortality risk. I have 2,293 underwent atherectomy. After previously shown, using ICD-9 billing propensity matching, a group of 3,047 remained to data, that the results of intervention with atherectomy compare between balloon angioplasty and stenting; 2,016 for patients presenting with claudication symptoms for comparison of angioplasty and atherectomy; and were worse than the natural history of the condition.”

1,656 between stenting and atherectomy. Patients were Mukherjee conceded there were limitations to the study, almost equally divided between claudicants and CLI. Most primarily owing to its observational nature, but concluded interventions were performed in the femoropopliteal-tibial that he and colleagues had demonstrated “stenting has segment. Results showed a “highly, highly significant” 30% better survival than angioplasty and 40% better than hazard ratio (HR) of 0.7 in favor of stenting vs. balloon atherectomy after propensity matching.”

July 2021

Say goodbye to tough.

Conquer every lesion you encounter with the most advanced peripheral atherectomy technology ever: the Auryon system1-3

Clear all lesion types, including severe calcifications, with a single device

Revolutionize how you treat, above and below the knee

The future has arrived. Deliver it to your patients.

To secure early access for your practice, visit:

Practice with confidence by minimizing the risk of embolization

Auryon-PAD.com

RISK INFORMATION Caution: Federal (USA) law restricts the use of the system by or on the order of a physician.

Refer to Directions for Use and/or User Manual provided with the product for complete Instructions, Warnings, Precautions, Possible Adverse Effects and Contraindications prior to use of the product.

INDICATIONS FOR USE The AURYON Atherectomy System is indicated for use in the treatment, including atherectomy, of infrainguinal stenoses and occlusions, including in-stent restenosis (ISR).

References: 1. Rundback J, Chandra P, Brodmann M, et al. Novel laser-based catheter for peripheral atherectomy: 6-month results from the Eximo Medical B-LaserTM IDE study.

Catheter Cardiovasc Interv. 2019;94(7):1010-1017. 2. Shammas NW, Chandra P, Brodmann M, et al. Acute and 30-day safety and effectiveness evaluation of Eximo Medical’s B-LaserTM , a novel atherectomy device, in subjects affected with infrainguinal peripheral arterial disease: results of the EX-PAD-03 trial. Cardiovas Revasc Med. 2020;21(1):86-92.

3. Auryon. Instructions for use. AngioDynamics; 2020.

AngioDynamics, the AngioDynamics logo, Auryon, and the Auryon logo are trademarks and/or registered trademarks of AngioDynamics, Inc., an affiliate or a subsidiary. © 2020 AngioDynamics, Inc. US/PA/AD/405 Rev 01 9/2020

VASCULAR PRACTICE PATIENT-REPORTED OUTCOMES

What are they and why should I care about them?

SVS Performance Committee members Mounir Haurani, MD, and Jose Almeida, MD, weigh up the importance of patientreported outcomes (PROs) and how they can be effectively deployed in practice.

MH: Patient reported outcomes (PROs) are direct reports from the patient of their health condition, health behavior or experience with healthcare, and are not subject to interpretation by the clinician or anyone but the patient. PRO measures (PROMs) are the tools that are used to evaluate PROs. JA: But PROs measure outcomes that aren’t relevant and we do not have many vascular disease-specific PROMs! MH: While clinicians and other stakeholders may value traditionally measured outcomes, those often do not reflect the patient experience of healthcare. PROs provide an unadulterated assessment of the patient’s perception of their own health status.

Importantly, a properly developed, validated PRO will address issues that are important to the patient.

PROMs fall into two major categories: health-related quality of life (HRQOL) and satisfaction. Most people are familiar with the Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS), which is a satisfaction survey that includes topics like cleanliness and

quietness of the hospital environment. I agree; those aren’t particularly relevant to vascular surgery; but, in fact, there are a number of vascular specific PROMs, such as the VascuQOL and the Peripheral Artery Questionnaire (PAQ) that can be used to assess treatment for peripheral arterial disease (PAD).

JA: Maybe you’ve convinced me that PROs have some value but collecting them sounds like just more paperwork in an endless battle against increased Mounir Haurani bureaucracy that detracts from patient care. Health and wellness task forces cite increased paperwork as a source of physician burnout. Post-op edema is clearly a real and debilitating problem that needs to be managed. Patients communicate this effectively with their voices when in the exam room. PROMs just add an additional barrier to personalized care—in that they make calculators and protocols

Introducing patient-reported outcomes into the VQI

BY DANIEL J. BERTGES, MD, AND JENS ELDRUP-JORGENSEN, MD

Vascular specialists have long recognized that there is more to the treatment of peripheral arterial disease (PAD) than the immediate procedural success and early outcomes.

THE PATIENT EXPERIENCE SHOULD NOT ONLY be measured in clinical outcomes such as patency or mortality but subjective measures such as the impact on lifestyle. In recognition of this, the Society for Vascular Surgery (SVS) Vascular Quality Initiative (VQI) has launched a pilot program of patient-reported outcomes measures (PROM) for use with peripheral vascular interventions (PVI).

12 | Vascular Specialist

tantamount to direct communication.

MH: There are ways that we can streamline the collection of PROs, such as the use of tablets that integrate with the electronic medical record (EMR) patients can fill out. Moving forward, the Centers for Medicare & Medicaid Services (CMS) will expect PROs to be measured and will use the results as performance standards for reimbursement. In order to provide the best care possible for our patients, and satisfy CMS requirements, it is important for us as vascular surgeons to be part of developing more vascular diseasespecific PROMs, as well as developing recommendations for efficiently and effectively integrating PROs into our practices. PROs will not replace quality listening, and thorough history and physical examinations. When a PRO is incorporated properly, we can use it to augment listening to and examining the patient.

How do I use PROs effectively?

MH: PROs can be used as a mechanism to quantify and discuss issues important Jose Almeida to patients. Using standardized, validated PROMs can allow us to have a common language when speaking with all stakeholders. Having reliable data on how the patient perceives their recovery to be progressing and their ability to resume their normal activities can help us better understand the barriers they face in returning to normal.

JA: I still think that the most important postoperative outcomes are our

Beginning in April 2021, 15 sites in the United States and Canada joined the My Peripheral Arterial Disease (My PAD) pilot for PAD PROM collection.

Patients undergoing PVI for claudication or chronic limb-threatening ischemia (CLTI) will be asked to complete two health-related quality of life (QoL) surveys at three time points—pre-procedure, one-month and one year.

While there are a number of options for PROM, the VQI chose two validated QoL instruments. The EuroQol 5D-5L (EQ 5D-5L) is a general QoL survey while the VascuQol 6 (VQ-6) is a vascular disease-specific survey used for PROM in Europe and validated for English and Spanish speakers. The VQI added three additional questions from the original VQ-25 in an effort to study and improve PRO collection for CLTI. The pilot will evaluate workflows at participating sites and aims to identify best strategies and minimize the burden of data collection.

The pilot will evaluate several methods for PROs collection, including web-based entry through personal computers, tablets and smartphones, as well as conventional, low-tech, paper forms.

Individual sites will choose their collection method and will have the option to use more than one mode of data entry. In an effort to reduce the burden of data collection at participating sites, the VQI commercial technology partner, Medstreaming/M2S, of West Lebanon, New Hampshire, will use email notifications to prompt

traditional measures like mortality and patency. Without achieving success in those traditional measures, the other issues that PROs address become irrelevant.

MH: I agree that PROs do not replace our traditional outcome measures. However, we can use PROs to improve the shared decision-making process. The difference between informed consent and shared decision-making is taking the patient’s goals into account when deciding on a treatment option. While the first question on the mind of most patients with an aortic aneurysm is, “What is my likelihood of surviving the surgery?”, the next question is often related to the recovery process. When we quantify patients’ HRQOL during the recovery process, we can use that information to help us objectively advise patients about their recovery process.

JA: The addition of PRO data will not fundamentally change the decisionmaking interaction between a doctor and an individual patient in a meaningful way. We do not know whether having this information ahead of time will better inform or instead confuse patients.

Patients rely on and trust their surgeon’s experience.

MH: In general, I’ve found that most patients are grateful for more information. And PROs can be used on an individual level. For example, a great way of utilizing a PRO in your daily practice is by using it to measure change in HRQOL before and after an intervention.

Sometimes it can be difficult for patients to remember how much disability they had before their operation for thoracic outlet syndrome. By using a PROM, you can quantify progress over time.

direct patient entry of PROs after obtaining their verbal consent to participate. The pilot will set the stage for future expansion of collection to all member sites in the PVI registry and eventually for rollout to cover other vascular procedures.

In the future, VQI PROs collection will enable international study in collaboration with European registries through the International Consortium of Vascular Registries (ICVR).

We envision a time when clinicians will have access to longitudinal PROs for their individual patients to better understand the impact of their treatments on their QoL. We hope this information will increase patient engagement, support shared decision-making and improve vascular care.

Beginning in April of 2021, 15 sites in the United States and Canada joined the My Peripheral Arterial Disease (My PAD) pilot for PAD PROM collection DANIEL J. BERTGES and JENS ELDRUP-JORGENSEN were writing on behalf of the Vascular Quality Initiative Patient-Reported Outcomes Committee. Jorgensen is medical director of the VQI. July 2021

SVS FOUNDATION

With Foundation help, more vascular care headed to Oklahoma

BY BETH BALES

There are new vistas in Oklahoma for those in need of vascular care.

T

hat’s “vista” as in Vascular Volunteers In Service To All, or VISTA, a new initiative of the Society for Vascular Surgery (SVS) Foundation whose mission is “to provide better vascular care to underserved populations in the United States,” said Jens Eldrup-Jorgensen, MD. He conceived of the initiative and brought it to the foundation. He is the medical director for the SVS Patient Safety Organization Vascular Quality Initiative and chairs the VISTA Program Steering Committee. SVS member Kelly Kempe, MD, is overseeing the first VISTA pilot project, “Disparities in access to care for limb salvage: The Oklahoma Project,” working with the state’s indigenous and rural populations. It builds on current outreach efforts in the state, some of which began as part of Kempe’s 2020 SVS Foundation Community Awareness and Prevention (CAPP) grant.

For both CAPP and this new disparities project, Kempe is working with a multidisciplinary team at the University of Oklahoma. It includes the Oklahoma Primary Healthcare Improvement Collaborative (OPHIC), medical informatics, internal medicine, podiatry, vascular imaging as well as Peter Nelson, MD, professor and chief of vascular surgery at the University of Oklahoma College of Medicine in Tulsa.

Kempe surveyed primary care providers (PCPs) throughout the state, asking them to identify barriers to limb salvage in Oklahoma, which has some of the highest rates of cardiovascular risk factors associated with amputation in the country. The survey also asked PCPs if they were interested in one-on-one conversations to further elucidate the same questions. “We’re identifying the beginning point. What do PCPs see as primary barriers to specific care that leads to major amputation?”

July 2021

said Kempe. “Why do our patients end up with severe chronic disease and with limb loss?”

Though the survey and qualitative data is currently being analyzed, PCPs told Kempe and colleagues they would welcome educational resources and awareness. When VISTA came up, “it made sense to utilize the community outreach data we have and keep building in our state.”

First up is to get a sense of the obstacles PCPs face, said Kempe.

VISTA volunteers will meet with the practices, distribute educational materials, discuss prevention that will include important physical exam signs, and provide tools such as portable doppler ultrasound equipment to check blood flow.

This will help the PCPs become more confident assessing circulation issues and providing more assistance for patients they’re worried about, Kempe said. The VISTA volunteers want to work to both increase PCPs’ awareness about warning signs and the care vascular surgeons can provide. Then, physicians will know to reach out to vascular surgeons when necessary—and be comfortable doing so, said Kempe.

Once they feel more confident assessing vascular disease, they will know who to call for help, she said.

And working with them is key, being collaborative and respectful of the work already being done, she said.

The initiative’s first location of Oklahoma is deliberate. The state has very few vascular providers— only 12—plus one of the highest percentage of rural communities in the country, as well as the largest

“Why do our patients end up with severe chronic disease and with limb loss?” — Kelly Kempe

VISTA addressing needs in underserved areas VISTA was born out of Jorgensen’s desire to reach out and do more. He said he’s always been a bit envious of colleagues who have gone overseas to do medical missionary work, he said in an appearance on the Audible Bleeding podcast. With the emphasis emerging over the past year on inequities, he brought a concept to bring modern vascular care to underserved communities to the SVS Foundation.

Refinements and revisions followed, with input from the American College of Surgeons to create VISTA. VISTA’s goal is awareness and prevention, and its initial project grants support initiatives that emphasize risk assessment and focus on bringing vascular care to areas of need.

VISTA organizers reached out to industry and corporate partners, many of whom had unspent funds when the COVID-19 pandemic forced cancellation of virtually all meetings, he said. “We were able to bring the VISTA idea to industry and say, ‘We have a project that addresses social disparities. Would you be interested in funding it?’ And actually, we got very quick turnaround on that.

“Interestingly, talking to corporations, we found out that their new employees want to know what the companies are doing to address social disparities,” said Jorgensen.

“This is a really a very opportune time for us.”

While Abbot is funding Kempe’s project, Boston Scientific is providing funding for two additional pilot projects.— Beth Bales

Native-American population in the country. Patients typically show up late in the disease process, when treatment options are more limited, doctors said. Collaborating with the local community, cardiologists, cardiothoracic, general, and vascular surgeons all will work to provide necessary care and resources. “The goal is to have active, ongoing outreach among practices, such that our understanding of the potential needs can evolve and our ability to both empower local caregivers and then provide referral support can grow,” said Kempe.

In the late summer and early fall, team members will begin holding the first in-person visits with targeted practices. After screening, patient education will also be provided.

“Oftentimes encouraging medical management, including diabetes care, stopping smoking and taking medication can potentially halt the disease,” said Kempe. “We discuss all avenues of prevention and do all we can so the disease doesn’t progress, and promote early detection when intervention may be warranted.”

As time goes on, the VISTA team will check back with the practices and physicians to find out what’s working and what they as volunteers can do better. Ultimately the model will be expanded to include information and assessment for aortic aneurysms, carotid disease and stroke, venous disease and hemodialysis needs.

“I want to emphasize how grateful I am to be a part of this project,” said Kempe. She thanked the SVS Foundation and said she’s grateful to have Nelson in her corner, as someone “who’s interested in doing things a little bit outside what some people consider research.” She said she believes community awareness work “is where sometimes we can have the biggest impact. If we can help patients, it’s a great honor.”

For more information on VISTA, visit vascular.org/VISTA.

vascularspecialistonline.com | 13

T

he Eastern Vascular Society is excited to host its 35th Annual Meeting as a hybrid: in person at the BELMOND Charleston Place in Charleston, SC, as well as broadcast virtually in the comfort of your own home and archived on our website.

WE ARE HYBRID! Virtual or In-Person Don’t miss important topics across vascular surgery through a combination of abstracts, invited talks, industry sponsored mini symposiums, and debates!

REGISTER NOW! events.easternvascular.org

Registration Types Member Physician Non-Member Physician Allied Health Member Allied Health Non-Member Candidate Member Residents/Fellows/Students

Early Rates - Until July 1 $375 $550 $225 $400 $50 $150

Regular Rates $425 $600 $275 $450 $100 $200

Reserve your room at the BELMOND Charleston Place Please reference EVS to take advantage of the group rates (until Aug 21) Meeting Registration

$359.00 Guest room (before tax) | $569.00 One Bedroom Suite (before tax)

Hotel Reservations

CONGRESS

The role of PACs in political influence

BY PETER CONNOLLY, MD, AND MARK MATTOS, MD

Let’s be clear here: Political action committees (PACs) are a good thing. Whether or not you like the concept, they create an opportunity for more people to be involved in the political process.

CONTRIBUTIONS BY PACs HAVE increased dramatically over the last decade. In 2020 nearly $500 million were donated to political campaigns. Given the magnitude of monies involved there is certainly some expectation that political donations will return some yield of political influence. Understanding the rationale of PAC donations, there are two main ways they are utilized: 1. The PAC hopes to influence the course of legislation by educating legislators on why they should take a specific action on a piece of legislation, such as co-sponsorship or voting for legislation when it is considered in committee or for passage. 2. The PAC

provides campaign contributions to those running for election who support the issues by having articulated policy positions that concern PAC members.

Patterns of PAC distributions tend to be directly proportional to elected officials’ influence on Capitol Hill. You need only look at the key members of the House of Representatives Ways and Means Committee, who receive the largest proportion of PAC donations, to appreciate PACs’ role in affecting the legislative process (see opensecrets.org).

There are 112 physician PACs, which gave $21 million in 2019–2020. While some of these PACs share common legislative interests, such as the relief from Prior Authorization requirements, there are a multitude of different legislative priorities for all of these groups. It is important for the SVS to have a voice in this element of the education process with members of Congress who sit on committees with jurisdiction over healthcare policy issues.

In our time being associated with the SVS PAC, it has become apparent that we will have greater influence on Capitol Hill with more direct engagement of our elected officials.

To that end, the Society for Vascular Surgery PAC (SVS PAC) and its committee, the SVS Government Relations and the SVS Advocacy and Policy Council have engaged in a tour-de-force advocacy campaign to bring the SVS legislative agenda front and center to our elected officials. During the 2019–2020 election cycles, the SVS PAC represented the SVS at nearly 25 events with members of

Town Halls to address wellness, appropriate use

BY BETH BALES

The Society for Vascular Surgery (SVS) has scheduled two Town Halls for the summer—one to cover vascular surgeon wellness programs (July 13) and the other to discuss the SVS’ first-ever appropriate use criteria (AUC) guidelines being developed on intermittent claudication.

(Aug. 5).

“ADVANCING VASCULAR SURGEON WELLNESS” will begin at 6 p.m. Central Daylight Time July 13.

Register at vascular.org/WellnessTownHall.

The Wellness Task Force will share updates about its initiatives to improve wellness for vascular surgeons, including the new surgeon coaching program, being developed by the SVS and the Academy for Surgical Coaching, which provides vascular surgeons with active support from other vascular surgeons. The volunteer

July 2021

Congress. We are on target to match or tool for advocacy efforts, grassroots exceed that number in just the first six actions where SVS members contact their months of the 2021–2022 election cycle. lawmakers are also critical. Having large SVS members representing 13 states numbers of SVS members respond to recently met with Reps. Dr. Kim Schrier our call for help last year in contacting (D-Washington), Ron lawmakers was a big Kind (D-Wisconsin), reason the Medicare Stephen Horsford cuts were halted (D-Nevada) and for 2021. To that gave Lizzie Fletcher end, the SVS physician million PACs (D-Texas), to discuss PAC, Government numerous legislative Relations Committee in priorities for vascular and the Policy and 2019– surgeons. SVS members Advocacy Council are 2020 engaged in a spirited dialogue sponsoring a Washington, D.C., with these officials, reviewing virtual fly-in event on July 21, as many of the hurdles part of a concentrated that we as vascular Grassroots Advocacy It’s not all about the surgeons face in the This virtual donations, but donations Week. politics of medicine event will match do bring opportunity as well as discussing and connect 40 to lawmakers’ perspective 50 SVS members from Capitol Hill. with their respective The takeaway was pretty clear—effective members of Congress for direct and frank political influence only works if you conversations about the challenges vascular have good advocacy. It’s not all about the surgeons faced in 2020 and looming donations, but PAC donations do bring obstacles we will face going forward in opportunity 2021 and 2022. Advocacy is key, but it is a Legislative priorities discussed included volume game; we can’t do it alone. Please protecting patients’ timely access to consider making a donation to the SVS care, prior authorization reform, holding PAC (visit vsweb.org/PAC) and marking physicians harmless from Medicare your calendars for the week of July 19 to cuts, stopping the practice of surprise participate in our week of grassroots action billing, support for increasing the number to give the SVS the strongest voice possible of residency positions, support for in the nation’s capital. telemedicine, increasing physician/surgeon wellness, and educating them on the PETER CONNOLLY and breadth and value of vascular surgery.

MARK MATTOS are co-chairs of the While having a PAC is an important SVS Political Action Steering Committee.

112

coaches are being trained this summer. Other topics will include subjects that have caused surgeons stress, including dealing more successfully with electronic medical records (EMRs), wellness and malpractice, the government’s role in physician wellness and reducing work-related pain and discomfort. Panelists include Dawn Coleman, MD, and Malachi Sheahan III, MD, task force co-chairs; London Guidry, MD, chair of the SVS Electronic Medical Records Subcommittee; Andrew Meltzer, MD, chair of the SVS Malpractice Support Subcommittee; Niten Singh, MD, chair of the SVS Coaching Subcommittee; Megan Tracci, MD, chair of the SVS Government Relations Committee; and Max Wohlauer, MD, chair of the Ergonomics Subcommittee.

The Aug. 5 Town Hall will discuss the “Society for Vascular Surgery appropriate use criteria for intermittent claudication.” This is the SVS’ first AUC and SVS members are leading this multidisciplinary work group, which includes members of both the American College of Cardiology and the Society of Interventional Radiology participating on the rating panel for a multidisciplinary approach. Panelists will include Kim Hodgson, MD, past SVS president; Larry Kraiss, MD, past chair of the SVS Quality Council; Jessica Simons, MD, chair of the new SVS Quality Improvement Committee; Jeffrey Siracuse, MD, past chair of the SVS Appropriateness Committee; and Karen Woo, MD, chair of the SVS Intermittent Claudication Appropriate Use Criteria Work Group.

The Town Hall will address appropriateness, the process and methodology of creating appropriate use criteria. Register at vascular.org/AUCTownHall.

$21

Upcoming SVS Town Halls cover wellness programs and appropriate use criteria

vascularspecialistonline.com | 15

August 2021 Issue 01

www.renalinterventions.net

Discrimination and harassment are a common experience among those working in cardiology According to the findings from a global survey carried out by the American College of Cardiology (ACC), which have been published in the Journal of the American College of Cardiology ( JACC). Responses suggest that as many as 44% of cardiologists report experiencing a hostile work environment (HWE) including being subject to emotional or sexual harassment, or discrimination.

Authors concluded that a renewed focus on organisational structure, processes, and practices to mitigate these problems in cardiology across the globe is critical to ensuring workforce wellbeing and optimal patient care.

The report is the culmination of a 50-item online survey conducted by the ACC in September to October 2019, reaching 5,931 cardiologists in Africa, Asia, the Caribbean, Europe, the Middle East, Oceana, and North,

Central, and South America. Questions covered demographic information, practice environment, academic rank, discrimination, and harassment, with a particular focus placed on the professional and personal challenges of cardiologists.

Author Garima Sharma ( Johns Hopkins School of Medicine, Baltimore, USA) noted that the incidences of HWE were more commonly reported among female (68%), Black (53%) and North American (54%) respondents.

Gender was the most frequent cause of discrimination (44%), the study found, followed by age (37%), race (24%), religion (15%), and sexual orientation (5%).

Of the participants 77% were

Balloon angioplasty in critical time window central to endovascular success for the slowto-mature AV fistula Discrimination and harassment are a common experience among those working in cardiology, according to the findings from a global survey carried out by the American College of Cardiology (ACC), which have been published in the Journal of the American College of Cardiology ( JACC). Responses suggest that as many as 44% of cardiologists report experiencing a hostile work environment (HWE) including being subject to emotional or sexual harassment, or discrimination.

A

uthors concluded that a renewed focus on organisational structure, processes, and practices to mitigate these problems in cardiology across the globe is critical to ensuring workforce wellbeing and optimal patient care.

The report is the culmination of a 50-item online survey conducted by the ACC in September to October 2019, reaching 5,931 cardiologists in Africa, Asia, the Caribbean, Europe, the Middle East, Oceana, and North, Central, and South America.

Questions covered demographic information, practice environment, academic rank, discrimination, and harassment, with a particular focus placed on the professional and personal challenges of cardiologists.

Author Garima Sharma ( Johns Hopkins School of Medicine, Baltimore, USA) noted that the incidences of HWE were more commonly reported among female (68%), Black (53%) and North American (54%) respondents. Gender was the most frequent cause of discrimination (44%), the study found, followed by age (37%), race (24%), religion (15%), and sexual orientation (5%).

Of the participants 77% were men (n=4,584), and 23% (n=1,347) were women. Survey participants predominantly identified as white (54%), followed by Asian (17%), Hispanic

(17%), and Black (3%); and 73% were ≤54 years of age. Most were married (75%); 12% were single, 7% were living with a partner, 3% were divorced, and 1% were separated. Cardiologists from the European Union represented the largest group of respondents (32%), followed by respondents from South America (18%), the Middle East, Eastern Europe and Asia (all 9%), Africa (8%), North America (7%), Central America (6%), and Oceana (2%).

According to Sharma, the survey results indicate that .

The report is the culmination of a 50-item online survey conducted by the ACC in September to October 2019, reaching 5,931 cardiologists in Africa, Asia, the Caribbean, Europe, the Middle East, Oceana, and North, Central, and South America.

Questions covered demographic information, practice environment, academic rank, discrimination, and harassment, with a particular focus placed on the professional and personal challenges of cardiologists.

Author Garima Sharma ( Johns Hopkins School of Medicine, Baltimore, USA) noted that the incidences of HWE were more commonly reported among female (68%), Black (53%) and North American (54%) respondents. Gender was the most frequent cause of discrimination (44%), the study found, followed by age (37%), race (24%), religion (15%), and sexual orientation (5%).

Of the participants 77% were men (n=4,584), and 23% (n=1,347) were women. Survey participants predominantly identified as white (54%), followed by Asian (17%), Hispanic (17%), and Black (3%); and 73% were ≤54 years of age. Most were married (75%); 12% were single, 7% were living with a partner, 3% were divorced, and 1% were separated.

Cardiologists from the European Union represented the largest group of respondents (32%), followed by respondents from South America (18%), the Middle East, Eastern Europe and Asia (all 9%), Africa (8%), North America (7%), Central America (6%), and Oceana (2%).

According to Sharma, the survey results indicate that The

Specialised source of news and education in the field of renal disease management Breaking news, in-depth analysis, and leading opinion from key industry figures Steered by globally-renowned physicians to monitor the latest innovations and controversies alike in the kidney care field Industry updates and real-time event coverage via social media, videos and more on print and digital platforms Visit www.renalinterventions.net and click ‘Subscriptions’ for complimentary print subscription* and e-newsletter subscription** *Available for US and EU readers only **Available worldwide

OUTPATIENT PRACTICE

SVS creates section for members in community practice

BY BETH BALES

To better meet the needs of Society for Vascular Surgery (SVS) members who practice in the community setting, the SVS has approved a proposal to evolve its Community Practice Committee to a new Community Practice Section.

THE CHANGE PROVIDES MORE OPPORTUNITY than a committee with limited membership can, said Daniel McDevitt, MD, section chair. The new section integrates the existing Section on Outpatient and Office Vascular Care (SOOVC) and brings together the whole of the community practice environment.

The Community Practice Section will be optimally

positioned to further enhance SVS efforts in education, He cited last year’s advocacy to fight 7–10% Medicare advocacy, quality practice, ethics, research and member reimbursement cuts. Some of the Section’s first activities value from a community practice perspective. will take place at VAM. Thursday afternoon features SVS traditionally was more focused on the specialty’s content devoted entirely to the clinical and business science, said McDevitt. However, time has brought practices of the outpatient vascular lab. Saturday will changes not only to the Society itself but also to medical feature a three-hour postgraduate course of interest to care and society in general: Today, more and more SVS community practitioners: “Emergency vascular care in members are delivering patient care in community the community hospital: What is safe and reasonable?” settings, he said.

During the Thursday session, the Section leaders Community practitioners comprise a significant also will present the Excellence in Community Service percentage of SVS membership, he said. Change has Awards for both 2020 and 2021. come quickly within the past five or so years to provide McDevitt praised SVS Immediate Past President more programs and education for these Kim Hodgson, MD, and Ronald L. members.

Dalman, MD, current SVS president, “We are really an The Community Practice their endorsement of the inclusive society that for Committee chair was named to the proposal. “We are really an inclusive represents surgeons society that represents surgeons SVS Executive Board to directly represent those members’ interests. in a variety of venues” in a variety of venues,” McDevitt Webinars and sessions of interest at said. “We all appreciate the Society — Daniel McDevitt the Vascular Annual Meeting (VAM) embracing representing the entire have increased in number over the vascular community.” years. And with continuing need, SVS The Community Practice Section leadership embraced the idea of creating a separate is the third of its kind. Understanding the need and section to help community surgeons meet some of the desire for groups of members with a common interest challenges they face. to find and engage with one another beyond the scope “We have a lot of ideas as well as content,” said of committee work, in 2017 the SVS Executive Board McDevitt. Many external factors create stress and established “Sections” as a new organizational model. affect members’ ability to practice, including scope-ofAny group of 40 members of the SVS with a common practice, billing and legal concerns, outpatient-based interest or discipline can petition to become an SVS facilities, new employment models, increasing workloads section and if approved, provide “added value” for their and decreasing reimbursements. “To address these cohort of members in a variety of ways. Before now, concerns, we need a more robust level of membership since 2017 only two sections were formed, the PA Section engagement. It’s important to have the strong in 2017, and the Outpatient and Office Based Care representation SVS provides to advance our cause.”

Section, better known as SOOVC, in 2019.

OBLs: Reimbursement challenges and the key to success in the outpatient setting

BY BRYAN KAY

The ability to pivot in the face of changes to reimbursement while still meeting the needs of patients is a key facet of success in the office-based lab (OBL) setting. That was among the key messages delivered by Brian DeRubertis, MD, professor of surgery at UCLA School of Medicine in Los Angeles, in a talk delivered at the Pacific Northwest Endovascular Conference (PNEC) in Seattle (May 27– 28) focused on reimbursement issues in the context of OBLs—and whether or not this mode of outpatient setting can weather the challenges.

T

o demonstrate his point, DeRubertis used the example of arteriovenous (AV) access procedures for dialysis patients.

“Reimbursement issues are always key to the OBL setting,” he explained. “Just like any hospital setting, you need to make sure your reimbursements are enough to sustain the model. Reimbursements have been decreasing in recent years. There is often discussion of large decreases in July 2021

reimbursement or large changes, but there have not been significant changes over the last few years, in my opinion. We have seen a decrease by a few percentage points in various procedures each year. Now that does change—there are some procedures, such as AV access procedures for dialysis, which took somewhat major changes a couple of years back. I think as physicians we need to be aware of what these changes are to make sure the reimbursement is still

sufficient enough that we’re providing care for patients in a way that we think is the right way to care for them.”

DeRubertis said it was important to highlight some of the benefits of providing care in the office-based outpatient setting.

He referenced physician flexibility; autonomy and independence in care provision; the speed at which patients can be transported into the procedural suite; a nimble nature that enables adaptability to community needs; and increased safety.

Reimbursement challenges often rest on an ability to react to change, he noted, returning to the example of decreased payments for AV access procedures in the the OBL arena.

“But they increased in the ASC [ambulatory surgery center setting],” DeRubertis pointed out. “So some physicians have converted and gone through the process of converting their

OBL to ambulatory surgery centers, which has a different set of requirements and regulations, but in some ways that’s maybe a good trend going forward for some centers.

“So I think the real key is being aware of reimbursements, and being able to pivot to make sure that it is in concordance with a model that allows us to treat our patients the right way.”

DeRubertis also touched on the ways in which COVID-19 demonstrated other OBL benefits.

While in a hospital patients attending for a lower-extremity angiogram might interact with as many as 30 different staff members, the equivalent number in an OBL or ASC might be just five to seven, he said. “So during such an unusual time like the pandemic, having that real simplicity and pareddown support staff really helped protect both patients and staff from COVID-19 transmission.”

Brian DeRubertis

vascularspecialistonline.com | 17

COMMENTARY

Corner Stitch

This month: New beginnings

Acing the final training years

BY CHRISTOPHER AUDU, MD

In academia, the start of summer brings about new beginnings and a changing of the guard. Chief residents and senior fellows graduate and start new jobs. This month, we decided to pick some of their brains to share their lived experiences and lessons learned for those who will be transitioning. Although 2020 was an unusual year to be a senior trainee in vascular surgery given the clinical repurposing that occurred due to COVID-19, there are still lessons to glean from the experience of our graduates.

CONTRIBUTING TO THIS COLUMN are Zachary Wanken, MD, a Dartmouth integrated vascular residency graduate and new Washington University, St. Louis, vascular surgeon; Ignatius Lau, MD, a Mt. Sinai integrated vascular residency graduate and now vascular surgeon in Northern California; Brandon Downing, MD, a Washington University, St Louis, integrated vascular graduate and newest Community Health Network, Indianapolis, Indiana, vascular surgeon; and Laura Maria Drudi, MD, who recently became a University of Montreal, Canada, vascular surgeon. Juggling the final years of training and an active job search takes deliberation and discipline. Here’s what our columnists had to share about doing both with aplomb.

Operate ZW: My #1 goal during my senior year was to make sure I became independently capable as an operative surgeon, both technically and from a decision-making standpoint. To that end, I scrubbed the most complex cases on our schedule and made sure to scrub a wide breadth of cases, too.

IL: Success as a chief resident or senior fellow boils down to operating as much as possible. The best learning occurs in the trenches of the operating room (OR), where mistakes may be made, near misses are discussed and emergencies are handled deftly. This stuff isn’t written in books. The only way to gain this knowledge is to increase the total number of cases that you do. As a chief, I chose high and low complexity cases to prepare me for what was to come.

18 | Vascular Specialist

LMD: The final year of training in Canada amidst a pandemic was challenging. I had to juggle chief responsibilities, studying for the Royal College of Physicians and Surgeons of Canada licensing exam, fellowship planning, and managing my soon to be surgical practice. Therefore, my priority in my final year was to ensure I was a competent surgeon. I knew the case history, operative planning, and divided tasks during the cases to ensure all members in the team had an opportunity to learn and participate. As a result, that year I became a leader in and out of the OR and my confidence grew exponentially.

BD: For your own training, it is important to continue to do the little cases because you will likely be doing far more “smaller” cases at the beginning of your career. My co-contributors have made some very excellent points. My only addition is to be mindful that the last few months of training can lead to burnout.

Scheduling a vacation during those times is not a bad idea.

Develop your soft skills ZW: My last two years, I focused on developing my management, leadership and teaching skills. This gave me useful experience in a safe environment where I could lean on the experience of my attendings. Focusing on these skills also gave me insight into the type of job I wanted.

LMD: Throughout training, I participated in several professional, leadership and educational development activities through the likes of the SVS. I always

strive to be a better physician, surgeon and person for my patients, my colleagues and myself.

I developed a reputation of being a compassionate and empathetic surgical leader. In terms of management skills, I feel it is a constant struggle for me to balance and integrate the various aspects of my life and career. Rather than view this balancing act as a struggle, I choose to see it as an adventure.

BD: To be successful in your final year of training, it is very important that you continue to support the workflow of all trainees to keep morale high for all. As you know, surgery takes a team effort, and now you play a major role in making that team function.”

Know your career phenotype ZW: From my experience, the delineation between academic practice and private practice is an oversimplification. I think the job landscape actually offers a great variety of positions that don’t fit neatly within the traditional academic or private practice models. Therefore, it is more important to focus on what you want out of a job or career. For example, many academic or private practice jobs

“I think the job landscape actually offers a great variety of positions” incorporate research, trainee education, clinical trials, etc. I would recommend reviewing all available options.

IL: First, you have to figure out what pathway you may want to pursue.

There are timelines to consider also.

For instance, academic jobs tend to be available in the winter and later when budgets are released. Private practice jobs, on the other hand, can become available as early July of your final year.

Prospective private practice employers may want an answer within a month of an offer, which can be challenging if you’re considering multiple options..

LMD: Throughout my vascular surgery training I made an intentional effort to brand my name and image, knowing that I have always wanted to become an academic vascular surgeon, and knowing that the job market is limited in Canada.

However, I followed my passions and

opportunities opened up for me to pursue the career I wanted. Through my postgraduate training in epidemiology, I became an expert in frailty and vulnerability for patients with PAD. My branding came from several years of attending conferences, networking with vascular trainees and faculty, presenting research, and volunteering on committees.

Leverage your network IL: Once the last year of training starts, meet with the chief of your division or section, and with trusted mentors to ask for references and to tap into the connections that they have. Be honest with them about your goals and what you’re looking for in a job. Make an effort to go to conferences in person and meet people. Sometimes, the first interview happens at these meetings. Pro tip: Meet with the representatives from each of the device companies that you have come to know and work with over the years. More often than not, they will have colleagues in the region of the country where you may be considering.

ZW: Visiting your potential new job location, if you haven’t lived there before, is important. Also important is speaking with graduating residents/fellows or erstwhile partners of your new practice.

LMD: I have continuously networked with the vascular surgery community.

I attended my first VAM in 2011 and always attended even when I wasn’t presenting. I became passionate about vascular outreach. I even became a simulation instructor. I further engaged in committees that were meaningful to me given my lived experiences. I am truly looking forward to growing alongside the incredible mentors and sponsors who have been by my side along the way.

CHRISTOPHER AUDU is an integrated vascular surgery resident at the University of Michigan in Ann Arbor, Michigan.

July 2021

NEWS BRIEFS

#SVSTweetChat hits high levels of engagement

BY ANNA VECCHIO

SINCE THE INAUGURAL #SVSTWEETCHAT that covered early career advice went live on Twitter in April, the monthly social media initiative has proven to be a valuable and interactive resource for the vascular surgeon community. It even inspired an episode of the increasingly popular Audible Bleeding, the vascular surgery podcast and formal entity of the Society for Vascular Surgery (SVS).

Members of the SVS Social Media Committee continue to update Twitter users on the progress of the chats through their personal accounts as well as the SVS social media channels.

The #SVSTweetChat has been well-received by panelists and participants—more than 360,000 users saw #SVSTweetChat in their timeline or search results during the May tweet chat covering radial access for the vascular surgeon.

Engagement levels have significantly increased since April’s Tweet edition, which earned more than 16,000 impressions. The success of the new social media initiative has inspired more members of the vascular community to get involved and keep the #SVSTweetChat conversation going on social media.

The April chat that inspired an episode of Audible Bleeding was part one of “So you’ve matched into vascular ... now what?” Hosts Matt Chia, MD, and Ali Irshad, MD, sat down with Regina Husman, MD, and Kirthi Bellamkonda, MD, to discuss how newly matched vascular residents can set themselves up for success in their residencies.

“We reached out on Twitter and asked the audience to send us questions for this episode … We want to thank Meryl Logan, MD, for inspiring this episode with the #SVSTweetChat,” said Chia.

Thirty-six Twitter users participated in the May tweet chat and more than 150 tweets featured the #SVSTweetChat hashtag. The @VascularSVS Twitter account gained 10 new followers within 24 hours of the chat.

Chats are held on the third Thursday of each month. The next tweet chat will kick off at 8 p.m.

Central Daylight Time Thursday, July 15, with a new set of panelists to discuss percutaneous vs. traditional arteriovenous fistula creation.

To participate, log in to Twitter at the time of the chat, search for #SVSTweetChat in the search bar at the upper right and look for the latest thread of tweets. To respond and engage with the chat, include the hashtag, #SVSTweetChat, in each response.

July 2021

Final Meet the Experts session is July 15 PRACTICING VASCULAR SURGEONS, LEARN ALL about preventing and managing type II endoleaks—a common situation faced by specialist—from the experts on July 15. Benjamin Jackson, MD, will moderate the session, alongside panelists Wei Zhou, MD, and Sunita Srivastava, MD. Participation is limited to 100 people so attendees have the opportunity to talk with the experts, asking questions, as well as relaying stories of their own cases and complications.

“Type II endoleak prevention and management,” from 7 to 8 p.m. Central Daylight Time, is the final of the four-session “Meet the Experts Webinar Series,” tackling a topic relevant to vascular surgeons in practice.

Vascular surgeons often confront type II endoleaks in patients who have undergone endovascular aneurysm repair (EVAR). The optimal treatment and prevention of this common problem is uncertain, and different vascular surgeons manage type II endoleaks differently.

Furthermore, some of these common endoleaks might be prevented by deploying embolization techniques or other measures at the time of the initial aneurysm repair, but indications to prophylactically treat lumbar vessels or the inferior mesenteric artery are uncertain. Part of the webinar will cover identification of indications for conversion to open aneurysm repair.—Beth Bales

Don’t miss out on learning how to better manage and prevent type II endoleaks. Learn more and register at vascular. org/MeetExperts.

OnDemand courses A NEW SOCIETY FOR VASCULAR SURGERY (SVS) OnDemand course, “Thoracoabdominal aneurysm repair” is now available on the Education Portal for members. It is one of eight courses now available in the “Vascular Atlas” section of SVS OnDemand. The Atlas is an online medical resource, with new courses added on a rolling basis, that provide up-to-date information to assist in patient care. SVS members update the courses.

Christopher Abularagge, MD, and James Black III, MD, both of Johns Hopkins Medicine, Washington, D.C., teach the thoracoabdominal aneurysm repair course. As is the case with all eight selections, it covers such factors as indications, pertinent anatomy, equipment needed, key steps, complications and more.

Other courses include “Hemodialysis access creation with upper extremity AV fistula,” by Bradley Bowles, MD, Michael Williams, MD, and Matthew R. Smeds, MD; “Renal artery stenting,” from Efthymios Avgerinos, MD; “Popliteal venous aneurysm by closed venous plication,” delivered by Andrea Obi, MD, Thomas Wakefield, MD, and Dawn Coleman, MD; “Thoracic outlet syndrome,” from Ying Wei Lum, MD, and Christopher J. Abularrage, MD; and “An approach to wound care for vascular surgeons, by Michael Go, MD. Any SVS member in good standing may view the Vascular Atlas courses. Start by visiting vascular.org/Education.—Beth Bales

Obituary Robyn Macsata, MD, 50, suddenly, May 21. She was chief of vascular surgery and associate professor of surgery at the George Washington University, Washington.

D.C. George Washington University Surgery posted online, “Her extraordinary legacy as a gifted surgeon, dynamic educator and supportive mentor will live on here at [George Washington] and in the lives of all of those she touched … [hers was] a life of excellence and a legacy that will live on in our community and beyond.”

Macsata received Society for Vascular Surgery Distinguished Fellow designation in 2019.—Beth Bales

vascularspecialistonline.com | 19